CRP and rheumatoid arthritis: Approximately 45% of patients in our final study cohort had evidence of high RA disease activity (DAS28-CRP > 3.1) (N = 326), paralleling the number/percentage of patients (322 patients, 44%) with high HAQ scores (HAQ > 1.9).